EA200001104A1 - Ascorbat Paroxetine - Google Patents

Ascorbat Paroxetine

Info

Publication number
EA200001104A1
EA200001104A1 EA200001104A EA200001104A EA200001104A1 EA 200001104 A1 EA200001104 A1 EA 200001104A1 EA 200001104 A EA200001104 A EA 200001104A EA 200001104 A EA200001104 A EA 200001104A EA 200001104 A1 EA200001104 A1 EA 200001104A1
Authority
EA
Eurasian Patent Office
Prior art keywords
paroxetine
ascorbat
published
useful
international
Prior art date
Application number
EA200001104A
Other languages
Russian (ru)
Inventor
Майкл Уркьюхарт
Original Assignee
Смитклайн Бичам Плс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Смитклайн Бичам Плс filed Critical Смитклайн Бичам Плс
Publication of EA200001104A1 publication Critical patent/EA200001104A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Аскорбат пароксетина полезен для лечения некоторых расстройств ЦНС.Международная заявка была опубликована вместе с отчетом о международном поиске.Paroxetine Ascorbate is useful for treating certain CNS disorders. The international application was published with an international search report.

EA200001104A 1998-04-25 1999-04-23 Ascorbat Paroxetine EA200001104A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9808896.6A GB9808896D0 (en) 1998-04-25 1998-04-25 Novel compound
PCT/GB1999/001244 WO1999055698A1 (en) 1998-04-25 1999-04-23 Paroxetine ascorbate

Publications (1)

Publication Number Publication Date
EA200001104A1 true EA200001104A1 (en) 2001-04-23

Family

ID=10831008

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200001104A EA200001104A1 (en) 1998-04-25 1999-04-23 Ascorbat Paroxetine

Country Status (20)

Country Link
EP (1) EP1089995A1 (en)
JP (1) JP2002513019A (en)
KR (1) KR20010042977A (en)
CN (1) CN1297448A (en)
AP (1) AP2000001963A0 (en)
AU (1) AU3618499A (en)
BG (1) BG104940A (en)
BR (1) BR9909868A (en)
CA (1) CA2330055A1 (en)
EA (1) EA200001104A1 (en)
GB (1) GB9808896D0 (en)
HU (1) HUP0102116A3 (en)
ID (2) ID26654A (en)
IL (1) IL139081A0 (en)
NO (1) NO20005352D0 (en)
PL (1) PL343677A1 (en)
SK (1) SK15912000A3 (en)
TR (1) TR200003084T2 (en)
WO (1) WO1999055698A1 (en)
ZA (1) ZA200005912B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
IL159280A0 (en) * 2001-06-14 2004-06-01 Teva Pharma A process for preparing paroxetine hcl which limits formation of pink colored compounds
ES2412306T3 (en) 2002-01-09 2013-07-11 Emisphere Technologies, Inc. Sodium 4 - ((4-Chloro-2-hydroxybenzoyl) amino) butanoate polymorphs
CN110607554B (en) * 2018-10-30 2024-03-22 中国科学院化学研究所 Method for preparing medicine or medicine intermediate monocrystal or amorphous substance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
DE3688827T2 (en) * 1985-10-25 1994-03-31 Beecham Group Plc Piperidine derivative, its manufacture and its use as a medicine.
US5276042A (en) * 1993-04-16 1994-01-04 Crenshaw Roger T Treatment of premature ejaculation
ES2117557B1 (en) * 1996-02-29 1999-07-01 Ferrer Int NEW PROCEDURE FOR OBTAINING (-) - TRANS -N-P-FLUOROBENZOILMETIL-4- (P-FLUOROFENIL) -3- ((3,4- (METHYLENDIOXI) PHENOXI) METHYL) -PIPERIDINE.

Also Published As

Publication number Publication date
WO1999055698A1 (en) 1999-11-04
AU3618499A (en) 1999-11-16
HUP0102116A3 (en) 2002-12-28
IL139081A0 (en) 2001-11-25
JP2002513019A (en) 2002-05-08
BG104940A (en) 2001-09-28
ID26083A (en) 2000-11-23
SK15912000A3 (en) 2001-04-09
ZA200005912B (en) 2001-12-19
HUP0102116A2 (en) 2002-05-29
EP1089995A1 (en) 2001-04-11
CN1297448A (en) 2001-05-30
PL343677A1 (en) 2001-08-27
NO20005352L (en) 2000-10-24
NO20005352D0 (en) 2000-10-24
GB9808896D0 (en) 1998-06-24
TR200003084T2 (en) 2001-02-21
CA2330055A1 (en) 1999-11-04
BR9909868A (en) 2000-12-19
ID26654A (en) 2001-01-25
KR20010042977A (en) 2001-05-25
AP2000001963A0 (en) 2000-12-31

Similar Documents

Publication Publication Date Title
EA199800667A1 (en) NEW PHENANTRIDINES
ATE297898T1 (en) 4-CARBOXAMINO-2-SUBSITUTED-1,2,3,4-TETRAHYDROCINOLINES AS CETP INHIBITORS
ATE277906T1 (en) 4-CARBOXAMINO-2-METHYL-1,2,3,4-TETRAHYDROCHINOLINES AS CETP INHIBITORS
ES2181730T3 (en) SUBSTITUTED PYRIDILPIRAZOLES.
PT931788E (en) METALOPROTEASE INHIBITORS
DE69917790D1 (en) 4-AMINO SUBSTITUTED -2-SUBSITUTE-1,2,3,4-TETRAHYDROCHINOLINE AS CETP INHIBITORS
EA200000098A1 (en) 4-AMINOPIRROL (3,2-d) Pyrimidine as antagonists of the neuropeptide Y neuropeptide
DE69706019D1 (en) Self-adjusting, vibration damping device
ATE427300T1 (en) HETEROCYCLIC SUBSTITUTED AMIDES AS CALPAIN INHIBITORS
YU48698A (en) Carboxamide derivatives of pyrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorder
EA199900362A1 (en) NEW CONNECTIONS USEFUL FOR USE AS NEURAL PROTECTIVE FACILITIES
DK0952154T3 (en) N-acyl and N-aroylaralkylamides
EA200100854A1 (en) CALCIUM-LITICAL COMPOUNDS
EA200100517A1 (en) ANTAGONISTS 5HT1 FOR ANTIDEPRESSANT THERAPY
AR022321A1 (en) USEFUL ANTI-CONVULSIVE DERIVATIVES FOR THE TREATMENT OF TRANSFORMED MIGRANE
EA200000561A1 (en) TRIAZINE CONNECTIONS FOR THE TREATMENT OF CNS DISORDERS
EA199800753A1 (en) BENZOTIOPHENES, COMPOSITIONS THEIR CONTAINING AND METHODS USING THEM
EA200001104A1 (en) Ascorbat Paroxetine
EA200100051A1 (en) FKBP INHIBITORS
ATE251457T1 (en) SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINE AND 2-AMINOCYCLOHEPTA(B)BENZOFURANES
EA200200798A1 (en) CALCYLYTIC COMPOUNDS
EA200500878A1 (en) CALCYLYTIC COMPOUNDS
EA200001105A1 (en) 10-Camforsulfonat Paroxetine for the treatment of CNS disorders
EA200001153A1 (en) CLEANING CARBOXALDEHYDE
FI910896A0 (en) 6-SUBSTITUERADE HEXAHYDROBENS (CD) INDOLER.